Real World Data Collection on the INSPIRIS RESILIA Aortic Valve
A Prospective, Observational Registry Study Designed to Collect Real-world Hemodynamic and Clinical Outcomes of the INSPIRIS RESILIA Aortic Valve
Edwards Lifesciences
500 participants
Jul 30, 2025
OBSERVATIONAL
Conditions
Summary
Collect real-world data on hemodynamic and clinical outcomes of the INSPIRIS RESILIA Aortic Valve, Model 11500A, in subjects requiring replacement of their native or prosthetic aortic valve as the only heart valve procedure during the index procedure, with or without other concomitant procedures.
Eligibility
Inclusion Criteria4
- Patients requiring an aortic valve replacement using the INSPIRIS RESILIA aortic valve according to its intended purpose
- Patients with standard-of-care pre-procedure imaging evaluation (echocardiography and CT) data available
- Age ≥ 18 years
- Provision of written informed consent
Exclusion Criteria3
- Active endocarditis/myocarditis or endocarditis/myocarditis within 3 months prior to the scheduled aortic valve replacement surgery
- Emergency procedure
- Patients requiring a non-aortic heart valve procedure during the index procedure
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Surgical replacement of the aortic valve with the Edwards INSPIRIS RESILIA Aortic Valve
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07120048